Maternal Arterial Hypertension
Arterial hypertension (AH) which is uncontrolled during pregnancy increases the incidence of prematurity and intrauterine malnutrition, which can lead to problems in the establishment of breastfeeding (Lawrence 2016 p.565).
There are no differences in the sodium and potassium content in the colostrum of mothers with AH and without AH (Sírio 2007).
Breastfeeding may be therapeutic for maternal AH. Prolactin is a relaxant for the mother and the breast is an organ of excretion that produces about a litre a day, so diuretics should be prescribed at a lower dose (Countouris 2016, Lawrence 2016 p.595).
A healthy diet, low in salt, and exercise are essential in the prevention and treatment of hypertension.
Pharmacological treatment of hypertension includes diuretics and antihypertensives.
Among diuretics, acetazolamide, chlorothiazide, hydrochlorothiazide, and spironolactone are minimally excreted in milk and are compatible with breastfeeding (Malachias 2016, Lawrence 2016 p.595).
In almost all therapeutic antihypertensive groups there is one or more which are considered compatible with breastfeeding: hydralazine and methyldopa; labetalol and propranolol; diltiazem, nifedipine and verapamil; captopril and enalapril are some of them (Anderson 2018, Malachias 2016).
Breastfeeding decreases maternal risk of developing hypertension and cardiovascular disease (Park 2018, Zhang 2015, Stuebe 2011, Schwarz 2009).
See below the information of these related products:
- Acetazolamide (Very Low Risk)
- Captopril (Very Low Risk)
- Chlorothiazide (Very Low Risk)
- Diltiazem Hydrochloride (Very Low Risk)
- Enalapril (Very Low Risk)
- Hydralazine Hydrochloride (Very Low Risk)
- Hydrochlorothiazide (Very Low Risk)
- Labetalol Hydrochloride (Very Low Risk)
- Methyldopa (Very Low Risk)
- Nifedipine (Very Low Risk)
- Propranolol (Very Low Risk)
- Spironolactone (Very Low Risk)
- Sport (Very Low Risk)
- Verapamil Hydrochloride (Very Low Risk)
See below the information of these related groups:
- Anti-hypertensive Anti Alpha-adrenergics, Vasodilators & other. ATC C02
- Anti-hypertensive Beta-Adrenergic blockers. ATC C07
- Anti-hypertensive Calcium channel-Blocker. ATC C08
- Anti-hypertensive. Angiotensin II receptor antagonists (ARBs, sartans). ATC C09C
- Anti-hypertensive. Angiotensin-converting enzyme (ACE) inhibitors. ATC C09A
- Diuretics ATC C03
Very Low Risk
Compatible. Not risky for breastfeeding or infant.
Low Risk
Moderately safe. Mild risk possible. Follow up recommended. Read the Comment.
High Risk
Poorly safe. Evaluate carefully. Use a safer alternative. Read the Comment.
Very High Risk
Not recommended. Cessation of breastfeeding or alternative.
Synonyms
- Maternal HT
Writings
- Αρτηριακή Υπέρταση μητέρας (Greek)
References
- Park S, Choi NK. Breastfeeding and Maternal Hypertension. Am J Hypertens. 2018Abstract
- Anderson PO. Treating Hypertension During Breastfeeding. Breastfeed Med. 2018Abstract
- Lawrence RA, Lawrence RM. Breastfeeding. A guide for the medical profession. Eighth Edition. Philadelphia: Elsevier; 2016
- Malachias MV, Figueiredo CE, Sass N, Antonello IC, Torloni MR, Bortolotto MRF L. 7th Brazilian Guideline of Arterial Hypertension: Chapter 9 - Arterial Hypertension in pregnancy Arq Bras Cardiol. 2016Abstract Full text (link to original source) Full text (in our servers)
- Countouris ME, Schwarz EB, Rossiter BC, Althouse AD, Berlacher KL, Jeyabalan A, Catov JM. Effects of lactation on postpartum blood pressure among women with gestational hypertension and preeclampsia. Am J Obstet Gynecol. 2016Abstract
- Zhang BZ, Zhang HY, Liu HH, Li HJ, Wang JS. Breastfeeding and maternal hypertension and diabetes: a population-based cross-sectional study. Breastfeed Med. 2015Abstract
- Stuebe AM, Schwarz EB, Grewen K, Rich-Edwards JW, Michels KB, Foster EM, Curhan G, Forman J. Duration of lactation and incidence of maternal hypertension: a longitudinal cohort study. Am J Epidemiol. 2011Abstract
- Schwarz EB, Ray RM, Stuebe AM, Allison MA, Ness RB, Freiberg MS, Cauley JA. Duration of lactation and risk factors for maternal cardiovascular disease. Obstet Gynecol. 2009Abstract
- Ghanem FA, Movahed A. Use of antihypertensive drugs during pregnancy and lactation. Cardiovasc Ther. 2008Abstract Full text (link to original source) Full text (in our servers)
- Sírio MA, Silva ME, Paula Hd, Passos MC, Souza Sobrinho AO. [Clinical and epidemiological determinants of sodium and potassium levels in the colostrum of breastfeeding mothers with and without hypertension in Brazil]. Cad Saude Publica. 2007Abstract